Published in Scand J Gastroenterol on August 01, 2007
Is moderate red wine consumption safe in inactive inflammatory bowel disease? Digestion (2011) 1.49
Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol (2010) 1.01
Diet in subjects with irritable bowel syndrome: a cross-sectional study in the general population. BMC Gastroenterol (2012) 0.83
Wine consumption and intestinal redox homeostasis. Redox Biol (2014) 0.81
Effects of five different drinks on patients with Crohn's disease. Scand J Gastroenterol (2009) 0.76
Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study. PLoS One (2016) 0.75
Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol (2009) 2.79
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C. Hepatology (2014) 1.73
Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2007) 1.49
[Does generic lamotrigine lead to larger variations in plasma concentrations?]. Ugeskr Laeger (2007) 1.41
Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer (2010) 1.40
[Pharmacokinetic differences in the ingestion of alcopops versus pure ethanol]. Ugeskr Laeger (2004) 1.39
Vitamin D levels, microvascular complications, and mortality in type 1 diabetes. Diabetes Care (2011) 1.28
Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2007) 1.27
The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2009) 1.24
Vitamin D levels and mortality in type 2 diabetes. Diabetes Care (2010) 1.21
Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol (2010) 1.15
Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol (2007) 1.12
Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care (2011) 1.04
Development and evaluation of an ELISA for human trefoil factor 3. Clin Chem (2002) 0.90
Severe deficiency of 25-hydroxyvitamin D₃ (25-OH-D₃) is associated with high disease activity of rheumatoid arthritis. Clin Rheumatol (2013) 0.88
Ischemic pre- and postconditioning has pronounced effects on gene expression profiles in the rat liver after ischemia/reperfusion. Am J Physiol Gastrointest Liver Physiol (2012) 0.88
The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment. Growth Horm IGF Res (2006) 0.87
The insulin-like growth factor (IGF) system and its relation to infliximab treatment in adult patients with Crohn's disease. Scand J Gastroenterol (2007) 0.87
Description of patients with midgut carcinoid tumours: clinical database from a Danish centre. In Vivo (2007) 0.84
Metabolic changes in the pig liver during warm ischemia and reperfusion measured by microdialysis. J Gastrointest Surg (2007) 0.83
Treatment of ascites and spontaneous bacterial peritonitis - part I. Dan Med J (2012) 0.81
Saliva Interleukin-6 in patients with inflammatory bowel disease. Scand J Gastroenterol (2005) 0.79
Discharge diagnoses of liver diseases in Nuuk Greenland compared to a Danish county hospital. Int J Circumpolar Health (2006) 0.78
Effects of long-acting somatostatin analogues on adrenal growth and phosphoribosyl pyrophosphate formation in experimental diabetes. Int J Exp Pathol (2012) 0.78
Expression of genes involved in rat liver angiogenesis after ischaemia and reperfusion: effects of ischaemic pre- and post-conditioning. HPB (Oxford) (2010) 0.78
The IGF system after insertion of a transjugular intrahepatic porto-systemic shunt in patients with liver cirrhosis. Eur J Endocrinol (2009) 0.77
Effect of combination therapy with a calcium channel blocker and an angiotensin-converting enzyme inhibitor on renal hypertrophy and urinary albumin excretion in diabetic rats. Exp Diabesity Res (2004) 0.77
Insulin-like growth factor binding protein 1 (IGFBP-1) in vaginal fluid in pregnancy. In Vivo (2004) 0.77
Tumor necrosis factor-alpha acutely up-regulates urea synthesis in vivo in rats--a hepatic component of inflammatory catabolism? Scand J Clin Lab Invest (2010) 0.76
Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure. Liver Int (2014) 0.76
Effects of urodilatin on natriuresis in cirrhosis patients with sodium retention. BMC Gastroenterol (2007) 0.76
Ascites from patients with alcoholic liver cirrhosis contains higher IGF-I bioactivity than serum. Clin Endocrinol (Oxf) (2009) 0.76
Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis. BMC Gastroenterol (2005) 0.76
Opposite effects on regulation of urea synthesis by early and late uraemia in rats. Clin Nutr (2007) 0.76
Insulin sensitivity and body composition in cirrhosis: changes after TIPS. Am J Physiol Gastrointest Liver Physiol (2010) 0.75
Effects of long-term experimental diabetes on adrenal gland growth and phosphoribosyl pyrophosphate formation in growth hormone-deficient dwarf rats. Int J Exp Pathol (2012) 0.75
[Vitamin D deficiency--a health problem?]. Ugeskr Laeger (2008) 0.75
Effects of long-acting somatostatin analogues on redox systems in rat lens in experimental diabetes. Int J Exp Pathol (2014) 0.75
Reply: To PMID 24623375. Hepatology (2015) 0.75
Body composition changes after transjugular intrahepatic portosystemic shunt in patients with cirrhosis. World J Gastroenterol (2010) 0.75
Growth hormone and growth hormone secretagogue effects on nitrogen balance and urea synthesis in steroid treated rats. Growth Horm IGF Res (2009) 0.75
The influence of amphotericin B and neomycin on the effect of human relaxin-2 on foetal membranes and isolated myometrium. Basic Clin Pharmacol Toxicol (2004) 0.75
[Liver biopsy in liver patients with coagulopathy]. Ugeskr Laeger (2008) 0.75
Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II. Dan Med J (2012) 0.75
[Treatment of bleeding esophageal varices. A 20-year old research-based successful history--how does it continue?]. Ugeskr Laeger (2007) 0.75
[Key issues for the number of publications by Ph.D. graduates in medicine and pharmaceutical sciences]. Ugeskr Laeger (2009) 0.75
[Vitamin D deficiency]. Ugeskr Laeger (2009) 0.75
[TIPS--transjugular intrahepatic portosystemic shunt. Experiences from a recently started center]. Ugeskr Laeger (2003) 0.75
Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroids. Scand J Gastroenterol (2005) 0.75
[Therapy of continuously bleeding oesophageal varices by self expanding metal stents]. Ugeskr Laeger (2007) 0.75
Unchanged capacity of urea synthesis during acute phase response in rats. Eur J Clin Invest (2010) 0.75
[Effect of healthy school meal on selection of blood parameters]. Ugeskr Laeger (2009) 0.75
Chemoembolization of intermediate stage hepatocellular carcinomas: results from a Nordic tertiary liver cancer center. Indian J Gastroenterol (2013) 0.75
[Screening for hepatocellular carcinoma?]. Ugeskr Laeger (2009) 0.75
[Nonalcoholic steatohepatitis. Three case reports]. Ugeskr Laeger (2003) 0.75